Corcept Therapeutics (CORT) Leases (2019 - 2025)
Corcept Therapeutics (CORT) has disclosed Leases for 7 consecutive years, with $4.6 million as the latest value for Q4 2025.
- Quarterly Leases fell 13.92% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2025, down 13.92% year-over-year, with the annual reading at $4.6 million for FY2025, 13.92% down from the prior year.
- Leases hit $4.6 million in Q4 2025 for Corcept Therapeutics, down from $4.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $5.7 million in Q2 2024 to a low of $61000.0 in Q1 2024.
- Historically, Leases has averaged $2.5 million across 5 years, with a median of $1.9 million in 2021.
- Biggest five-year swings in Leases: crashed 89.62% in 2023 and later surged 8337.7% in 2025.
- Year by year, Leases stood at $1.3 million in 2021, then fell by 9.43% to $1.1 million in 2022, then plummeted by 89.5% to $120000.0 in 2023, then soared by 4336.67% to $5.3 million in 2024, then fell by 13.92% to $4.6 million in 2025.
- Business Quant data shows Leases for CORT at $4.6 million in Q4 2025, $4.8 million in Q3 2025, and $5.0 million in Q2 2025.